# The Effectiveness and Tolerability of Fentanyl Matrix in Chronic Non-cancer Pain; Assessment of Patient's Pain Treatment Goal Achievement

> **NCT01688583** · — · COMPLETED · sponsor: **Janssen Korea, Ltd., Korea** · enrollment: 410 (actual)

## Conditions studied

- Chronic Pain

## Interventions

- **DRUG:** Fentanyl matrix

## Key facts

- **NCT ID:** NCT01688583
- **Lead sponsor:** Janssen Korea, Ltd., Korea
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 410 (ACTUAL)
- **Last updated:** 2013-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01688583

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01688583, "The Effectiveness and Tolerability of Fentanyl Matrix in Chronic Non-cancer Pain; Assessment of Patient's Pain Treatment Goal Achievement". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01688583. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*